Literature DB >> 10818586

Quantitative aspects of plasma/serum DNA in cancer patients.

P Anker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10818586     DOI： 10.1111/j.1749-6632.2000.tb06580.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.

Authors:  Thomas E Liggett; Anatoliy A Melnikov; Jeffrey R Marks; Victor V Levenson
Journal:  Int J Cancer       Date:  2010-04-05       Impact factor: 7.396

Review 2.  Urine-Based Liquid Biopsy for Nonurological Cancers.

Authors:  Surbhi Jain; Selena Y Lin; Wei Song; Ying-Hsiu Su
Journal:  Genet Test Mol Biomarkers       Date:  2019-04

3.  Detection of hypermethylated vimentin in urine of patients with colorectal cancer.

Authors:  Benjamin P Song; Surbhi Jain; Selena Y Lin; Quan Chen; Timothy M Block; Wei Song; Dean E Brenner; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2012-01-16       Impact factor: 5.568

4.  Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.

Authors:  Jason L Sanchez; Gregory A Storch
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Qualitative and quantitative characteristics of the extracellular DNA delivered to the nucleus of a living cell.

Authors:  Vladimir A Rogachev; Anastasia Likhacheva; Oksana Vratskikh; Lyudmila V Mechetina; Tamara E Sebeleva; Sergei S Bogachev; Leonid A Yakubov; Mikhail A Shurdov
Journal:  Cancer Cell Int       Date:  2006-10-11       Impact factor: 5.722

6.  Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation.

Authors:  T E Skvortsova; E Y Rykova; S N Tamkovich; O E Bryzgunova; A V Starikov; N P Kuznetsova; V V Vlassov; P P Laktionov
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

7.  Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.

Authors:  Anastasia S Proskurina; Tatiana S Gvozdeva; Ekaterina A Alyamkina; Evgenia V Dolgova; Konstantin E Orishchenko; Valeriy P Nikolin; Nelly A Popova; Sergey V Sidorov; Elena R Chernykh; Alexandr A Ostanin; Olga Y Leplina; Victoria V Dvornichenko; Dmitriy M Ponomarenko; Galina S Soldatova; Nikolay A Varaksin; Tatiana G Ryabicheva; Peter N Uchakin; Stanislav N Zagrebelniy; Vladimir A Rogachev; Sergey S Bogachev; Mikhail A Shurdov
Journal:  BMC Cancer       Date:  2015-03-13       Impact factor: 4.430

8.  Nasopharyngeal brushing: a convenient and feasible sampling method for nucleic acid-based nasopharyngeal carcinoma research.

Authors:  Pei-Fen Zhang; Xiao-Hui Zheng; Xi-Zhao Li; Tian Tian; Shao-Dan Zhang; Ye-Zhu Hu; Wei-Hua Jia
Journal:  Cancer Commun (Lond)       Date:  2018-04-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.